Smurfit Kappa Group Other Income (Expense) increased by 35.3% to -$11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 120.0%, from -$5.00M to -$11.00M. Over 2 years (FY 2022 to FY 2025), Other Income (Expense) shows a downward trend with a 101.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.75M | $3.75M | $3.75M | $3.75M | -$4.00M | -$27.00M | -$5.00M | $5.00M | -$13.00M | -$12.00M | -$5.00M | -$18.00M | -$21.00M | -$17.00M | -$11.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -206.7% | -575.0% | +81.5% | +200.0% | -360.0% | +7.7% | +58.3% | -260.0% | -16.7% | +19.0% | +35.3% |
| YoY Change | — | — | — | — | -206.7% | -820.0% | — | — | -225.0% | +55.6% | +0.0% | -460.0% | -61.5% | -41.7% | -120.0% |